Institutional members access full text with Ovid®

Emerging Oral Therapies for Multiple Sclerosis

Miller, Colleen E.; Umhauer, Margaret A.

Journal of Neuroscience Nursing: February 2011 - Volume 43 - Issue 1 - pp 3-14
doi: 10.1097/JNN.0b013e31820297a9
Article

Despite notable advances in the understanding of multiple sclerosis (MS) and the availability of several treatment options, there is a need for therapies that are more effective, safe, convenient, and well tolerated. Several new oral MS therapies are being investigated. Because data on these new therapies continue to emerge, nurses will play a pivotal role in educating patients regarding the benefits and risks of potential treatments and in monitoring patients for response, safety, tolerability, and adherence. This article reviews the oral MS therapies recently approved as well as those currently in development or submitted for Food and Drug Administration approval.

Margaret A. Umhauer, RN MS NP, is a nurse practitioner at the William C. Baird Multiple Sclerosis Research Center, Jacobs Neurological Institute, University at Buffalo, The State University of New York, Buffalo, NY.

Questions or comments about this article may be directed to Colleen E. Miller, RN NP DNS, at cmiller@TheJNI.org. She is a nurse practitioner at the William C. Baird Multiple Sclerosis Research Center, Jacobs Neurological Institute, University at Buffalo, The State University of New York, Buffalo, NY.

© 2011 American Association of Neuroscience Nurses